The Current Ratio as of December 2025 (TTM) for Taiwan Bio Therapeutics Co., Ltd (6892.TWO) is 8.15

According to Taiwan Bio Therapeutics Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 8.15. This represents a change of -5.35% compared to the average of 8.61 of the last 4 quarters.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Historical Current Ratio (quarterly & annually)

How has 6892.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Taiwan Bio Therapeutics Co., Ltd over the last ten years is 3.86. The current 8.15 Current Ratio has changed 21.00% with respect to the historical average. Over the past ten years (40 quarters), 6892.TWO's Current Ratio was at its highest in in the March 2024 quarter at 12.16. The Current Ratio was at its lowest in in the September 2023 quarter at 0.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Taiwan Bio Therapeutics Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Average Current Ratio

How has 6892.TWO Current Ratio performed in the past?

The current Current Ratio of Taiwan Bio Therapeutics Co., Ltd (6892.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) Current Ratio vs. Peers

How is 6892.TWO’s Current Ratio compared to its peers?

Taiwan Bio Therapeutics Co., Ltd’s Current Ratio is greater than Intech Biopharm Corporation (1.71), less than TaiRx, Inc. (20.60), greater than Steminent Biotherapeutics Inc. (6.33), less than Anti-Microbial Savior BioteQ Co., Ltd (18.78), less than HeXun Biosciences Co., Ltd. (8.26), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (3.10), greater than GlycoNex Incorporation (1.67), less than Sinew Pharma Inc. (53.40), greater than Sunny Pharmtech Inc. (1.30), greater than G&E Herbal Biotechnology Co., Ltd. (3.45),

Build a custom stock screener for Taiwan Bio Therapeutics Co., Ltd (6892.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiwan Bio Therapeutics Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taiwan Bio Therapeutics Co., Ltd (6892.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taiwan Bio Therapeutics Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.